Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Pediatr Nephrol. 2010 Feb;25(2):323-8. doi: 10.1007/s00467-009-1350-3. Epub 2009 Nov 28.
The aim of this study was to examine the association between blood pressure (BP) in children and adolescents and cardiovascular and renal disease in adulthood. This was a retrospective study on patients <18 years of age with an elective admission to Landspitali University Hospital in Reykjavik, Iceland, between 1950 and 1967. We recorded baseline variables including BP and invited all patients for a follow-up visit in 2008 for repeat studies. We used chi(2), Fisher's exact test, and logistic regression to examine the association between BP in childhood and outcome variables at follow-up. We identified 126 individuals (54 men) for the study. The median age (range) at childhood admission was 15 (10-17) years and the median BP was 125/80 mmHg. Median age at follow-up was 58 (42-68) years, follow-up time 43 (25-52) years, and median BP 133/75 mmHg. Eleven had died (five men) and 49 had been diagnosed with hypertension (23 men) and 12 with coronary artery disease (ten men). There was a significant correlation between the diagnosis of coronary artery disease at follow-up and childhood systolic BP (odds ratio = 1.052; P = 0.03) as well as systolic BP >/= 95th percentile (P = 0.03). Our results suggest that elevated childhood systolic BP may increase the risk of coronary artery disease in adult life. The sample size is a limiting factor, and the study should be carried out in a larger population.
本研究旨在探讨儿童和青少年时期的血压(BP)与成年后心血管和肾脏疾病之间的关系。这是一项回顾性研究,对象为 1950 年至 1967 年期间在冰岛雷克雅未克的 Landspitali 大学医院择期入院的<18 岁患者。我们记录了基线变量,包括血压,并邀请所有患者在 2008 年进行随访,以重复研究。我们使用卡方检验、Fisher 精确检验和逻辑回归来检验儿童时期的血压与随访时的结果变量之间的关系。我们确定了 126 名个体(54 名男性)进行研究。儿童时期入院时的中位数年龄(范围)为 15 岁(10-17 岁),中位数血压为 125/80mmHg。随访时的中位数年龄为 58 岁(42-68 岁),随访时间为 43 年(25-52 年),中位数血压为 133/75mmHg。有 11 人死亡(5 名男性),49 人被诊断为高血压(23 名男性),12 人被诊断为冠心病(10 名男性)。在随访中诊断为冠心病与儿童期收缩压呈显著相关(比值比=1.052;P=0.03),以及收缩压> = 95 百分位数(P=0.03)。我们的结果表明,儿童期收缩压升高可能会增加成年后冠心病的风险。样本量是一个限制因素,应在更大的人群中进行这项研究。